AbbVie M&A Summary
AbbVie has acquired 15 companies, including 10 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
AbbVie’s largest acquisition to date was in 2019, when it acquired Allergan for $63.0B. It’s largest disclosed sale occurred in 2020, when it sold Rare Pediatric Disease Priority Review Voucher to United Therapeutics for $105M. AbbVie has acquired in 8 different US states, and 3 countries. The Company’s most targeted sectors include life science (100%).
M&A Summary
-
M&A Total Activity16
- M&A Buy Activity15
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 3
- M&A Buy/Sell Connections 4
Unlimited Searches
